|
|
(46 intermediate revisions by the same user not shown) |
description / en | description / en |
- | Research article published in the journal Emerg Microbes Infect (2020)
| + | Research article published in Emerg Microbes Infect; 2020; 9(1) 582-585. |
| Property / License: cc-by / reference |
| + | |
| Property / Publication Date |
| + | 14 March 2020Timestamp | +2020-03-14T00:00:00Z |
---|
Timezone | +00:00 |
---|
Calendar | Gregorian |
---|
Precision | 1 day |
---|
Before | 0 |
---|
After | 0 |
---|
|
| Property / Publication Date: 14 March 2020 / rank |
| + | Normal rank |
| Property / Publication Date: 14 March 2020 / reference |
| + | |
| Property / Microsoft Academic ID |
| + | |
| Property / Microsoft Academic ID: No data / rank |
| + | Normal rank |
| Property / Microsoft Academic ID: No data / reference |
| + | |
| Property / COVIDWHO ID |
| + | |
| Property / COVIDWHO ID: 8788 / rank |
| + | Normal rank |
| Property / COVIDWHO ID: 8788 / reference |
| + | |
| Property / CORD-19 Internal Unique Identifier |
| + | 6wdwrttn |
| Property / CORD-19 Internal Unique Identifier: 6wdwrttn / rank |
| + | Normal rank |
| Property / CORD-19 Internal Unique Identifier: 6wdwrttn / reference |
| + | |
| Property / sha1 Hash for Publication |
| + | 51b99ff77b798aa00a8a10ecb4f62312a3f562d2 |
| Property / sha1 Hash for Publication: 51b99ff77b798aa00a8a10ecb4f62312a3f562d2 / rank |
| + | Normal rank |
| Property / sha1 Hash for Publication: 51b99ff77b798aa00a8a10ecb4f62312a3f562d2 / reference |
| + | |
| Property / CORD-19 Article Source String |
| + | PMC |
| Property / CORD-19 Article Source String: PMC / rank |
| + | Normal rank |
| Property / CORD-19 Article Source String: PMC / reference |
| + | |
| Property / Volume |
| + | TRUE |
| Property / Volume: TRUE / rank |
| + | Normal rank |
| Property / Volume: TRUE / reference |
| + | |
| Property / Issue |
| + | TRUE |
| Property / Issue: TRUE / rank |
| + | Normal rank |
| Property / Issue: TRUE / reference |
| + | |
| Property / CORD-19 Full Text File |
| + | comm_use_subset |
| Property / CORD-19 Full Text File: comm_use_subset / rank |
| + | Normal rank |
| Property / CORD-19 Full Text File: comm_use_subset / reference |
| + | |
| Property / Collection or Dataset of Origin |
| + | |
| Property / Collection or Dataset of Origin: COVID-19 Open Research Dataset (CORD-19). 2020. / rank |
| + | Normal rank |
| Property / has part |
| + | |
| Property / has part: Section 1: Introduction (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / has part |
| + | |
| Property / has part: Section 2: Protection requirements of medical personnel (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / has part |
| + | |
| Property / has part: Section 2.1: Selection of front-line personnel (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / has part |
| + | |
| Property / has part: Section 2.2: Isolation and protection requirements (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / has part |
| + | |
| Property / has part: Section 2.3: Isolation and observation of medical personnel after close contact with SARS-CoV-2 (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / has part |
| + | |
| Property / has part: Section 3: Diagnosis and treatment of SARS-CoV-2 infected patients (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / has part |
| + | |
| Property / has part: Section 3.1: Screening criteria (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / has part |
| + | |
| Property / has part: Section 3.2: Diagnostic criteria (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / has part |
| + | |
| Property / has part: Section 3.3: Examination routines of SARS-CoV-2 infected patient (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / has part |
| + | |
| Property / has part: Section 3.3.1: Screening cases on the day of visit (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / has part |
| + | |
| Property / has part: Section 3.3.2: Sequential examination of confirmed patients (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / has part |
| + | |
| Property / has part: Section 3.4: Place of treatment according to the severity of the disease (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / has part |
| + | |
| Property / has part: Section 3.4.1: Severe type (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / has part |
| + | |
| Property / has part: Section 3.4.2: Critically ill type (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / has part |
| + | |
| Property / has part: Section 3.5: Treatment (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / has part |
| + | |
| Property / has part: Section 3.5.1: General treatment (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / has part |
| + | |
| Property / has part: Section 3.5.2: Oxygen therapy (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / has part |
| + | |
| Property / has part: Section 3.5.2.1: Choice of oxygen therapy (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / has part |
| + | |
| Property / has part: Section 3.5.2.2: The way of respiratory support (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / has part |
| + | |
| Property / has part: Section 3.5.3: Antiviral treatment (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / has part |
| + | |
| Property / has part: Section 3.5.4: Glucocorticoid therapy (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / has part |
| + | |
| Property / has part: Section 3.5.5: Intravenous immunoglobulin (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / has part |
| + | |
| Property / has part: Section 3.5.6: Empirical antimicrobial therapy (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / has part |
| + | |
| Property / has part: Section 4: Protection and transfer (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / has part |
| + | |
| Property / has part: Section 5: Criteria of isolation release and discharge (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |
| Property / has part |
| + | |
| Property / has part: Disclosure statement (from DOI: 10.1080/22221751.2020.1735265) / rank |
| + | Normal rank |